Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration: A randomised controlled trial

Thrombosis and Haemostasis

Volumn 105, Issue 4, 2011, Pages 655-662

  Spiel, Alexander O ^a   Bartko, Johann ^a   Schwameis, Michael ^a   Firbas, Christa ^a   Siller Matula, Jolanta ^a   Schuetz, Matthias ^a   Weigl, Manuela ^a   Jilma, Bernd ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

G CSF; Gender difference; Platelets; Randomised controlled trial; Whole blood aggregometry

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; C REACTIVE PROTEIN; COLLAGEN; LACTATE DEHYDROGENASE; PADGEM PROTEIN; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RISTOCETIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG HALF LIFE; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NEUTROPHIL COUNT; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ADOLESCENT; ADULT; ARACHIDONIC ACID; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; P-SELECTIN; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; RISTOCETIN; SEX FACTORS; THROMBOSIS;

EID: 79955370074     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-08-0530     Document Type: Article

References (47)

1. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte- macrophage colony-stimulating factor (1). N Engl J Med 1992; 327: 28-35.
2. Majolino I, Cavallaro AM, Scime R. Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant 1996; 18 (Suppl 2): 171-174.
3. Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 1986; 67: 257-267.
4. Shimoda K, Okamura S, Harada N, et al. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J Clin Invest 1993; 91: 1310-1313.
5. Avenarius HJ, Freund M, Deinhardt J, et al. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on circulating platelets. Ann Hematol 1992; 65: 6-9.
6. Kaptan K, Ifran A, Beyan C, et al. Recombinant human granulocyte colony-stimulating factor (rhG-CSF) promotes in vitro platelet aggregation. Hematology 2007; 12: 441-444.
7. Shimoda K, Okamura S, Inaba S, et al. Granulocyte colony-stimulating factor and platelet aggregation. Lancet 1993; 341: 633.
8. LeBlanc R, Roy J, Demers C, et al. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors. Bone Marrow Transplant 1999; 23: 991-996.
9. Anderlini P, Champlin RE. Biologic and molecular effects of granulocyte colonystimulating factor in healthy individuals: recent findings and current challenges. Blood 2008; 111: 1767-1772.
10. Spiel AO, Siller-Matula J, Firbas C, et al. Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans. Platelets 2010; 21: 464-469.
11. Chong BH, Murray B, Berndt MC, et al. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 1994; 83: 1535-1541.
12. Jilma B, Dirnberger E, Eichler HG, et al. Sex differences in circulating P-selectin, E-selectin and thrombomodulin. Br J Haematol 1996; 95: 575-576.
13. Stohlawetz P, Hergovich N, Stiegler G, et al. Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P-selectin. Transfusion 1998; 38: 24-30.
14. Mayr FB, Spiel AO, Leitner JM, et al. Duffy antigen modifies the chemokine response in human endotoxemia. Crit Care Med 2008; 36: 159-165.
15. Patriccia R, Antonucci E, Maggini N, et al. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients. Thromb Haemost 2010; 104: 287-292.
16. Derhaschnig U, Jilma B. Assessment of platelets and the endothelium in patients presenting with acute coronary syndromes--is there a future? Thromb Haemost 2009; 102: 1144-1148.
17. Siller-Matula JM, Gouya G, Wolzt M, et al. Cross validation of the Multiple Electrode Aggregometry. A prospective trial in healthy volunteers. Thromb Haemost 2009; 102: 397-403.
18. Sibbing D, Schulz S, Braun S, et al. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost 2010; 8: 250-256.
19. Kalb ML, Potura L, Scharbert G, et al. The effect of ex vivo anticoagulants on whole blood platelet aggregation. Platelets 2009; 20: 7-11.
20. Siller-Matula JM, Christ G, Lang IM, et al. Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay. J Thromb Haemost 2010; 8: 351-359.
21. Sibbing D, Braun S, Jawansky S, et al. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008; 99: 121-126.
22. Sibbing D, Morath T, Braun S, et al. Clopidogrel response status assessed with Multiplate point-of-care analyses and the incidence and timing of stent thrombosis over six months following coronary stenting. Thromb Haemost 2010; 103: 151-159.
23. Kotzailias N, Graninger M, Knechtelsdorfer M, et al. Acute effects of hyperglycaemia on plasma concentration of soluble P-selectin and von Willebrand factor in healthy volunteers -a prospective randomised double blind controlled study. Thromb Res 2009; 123: 452-459.
24. Derhaschnig U, Reiter R, Knobl P, et al. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. Blood 2003; 102: 2093-2098.
25. Stohlawetz P, Horvath M, Pernerstorfer T, et al. Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans. Transfusion 1999; 39: 506-514.
26. Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 2003; 24: 2166-2179.
27. Mayr FB, Spiel AO, Leitner JM, et al. Racial differences in endotoxin-induced tissue factor-triggered coagulation. J Thromb Haemost 2009; 7: 634-640.
28. Anderlini P, Przepiorka D, Seong D, et al. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion 1996; 36: 590-595.
29. Jilma B, Hergovich N, Stohlawetz P, et al. Circadian variation of granulocyte colony stimulating factor levels in man. Br J Haematol 1999; 106: 368-370.
30. Stohlawetz PJ, Dzirlo L, Hergovich N, et al. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood 2000; 95: 2983-2989.
31. Haiden N, Cardona F, Schwindt J, et al. Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity. Thromb Haemost 2005; 93: 118-123.
32. Falanga A, Marchetti M, Evangelista V, et al. Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor. Blood 1999; 93: 2506-2514.
33. van Os R, van Schie ML, Willemze R, et al. Proteolytic enzyme levels are increased during granulocyte colony-stimulating factor-induced hematopoietic stem cell mobilization in human donors but do not predict the number of mobilized stem cells. J Hematother Stem Cell Res 2002; 11: 513-521.
34. Cerletti C, Evangelista V, Molino M, et al. Platelet activation by polymorphonuclear leukocytes: role of cathepsin G and P-selectin. Thromb Haemost 1995; 74: 218-223.
35. Renesto P, Chignard M. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation. Blood 1993; 82: 139-144.
36. Wohner N, Keresztes Z, Sotonyi P, et al. Neutrophil granulocyte-dependent proteolysis enhances platelet adhesion to the arterial wall under high-shear flow. J Thromb Haemost 2010; 8: 1624-1631.
37. Willis F, Theti D, Dean S, et al. Pegfilgrastim successfully mobilizes megakaryocyte progenitors into the peripheral blood in subjects with solid tumours. Bone Marrow Transplant 2008; 42: 167-173.
38. Lee DS, Larson MG, Lunetta KL, et al. Clinical and genetic correlates of soluble P-selectin in the community. J Thromb Haemost 2008; 6: 20-31.
39. Jilma B, Hildebrandt J, Kapiotis S, et al. Effects of estradiol on circulating P-selectin. J Clin Endocrinol Metab 1996; 81: 2350-2355.
40. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001; 103: 491-495.
41. Kisucka J, Chauhan AK, Zhao BQ, et al. Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis. Blood 2009; 113: 6015-6022.
42. Elwood PC, Beswick AD, Sharp DS, et al. Whole blood impedance platelet aggregometry and ischemic heart disease. The Caerphilly Collaborative Heart Disease Study. Arteriosclerosis 1990; 10: 1032-1036.
43. Elwood PC, Renaud S, Sharp DS, et al. Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation 1991; 83: 38-44.
44. Fukumoto Y, Miyamoto T, Okamura T, et al. Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br J Haematol 1997; 97: 666-668.
45. Vij R, Adkins DR, Brown RA, et al. Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte-colony-stimulating factor. Transfusion 1999; 39: 542-543.
46. Hill JM, Syed MA, Arai AE, et al. Outcomes and risks of granulocyte colonystimulating factor in patients with coronary artery disease. J Am Coll Cardiol 2005; 46: 1643-1648.
47. Zohlnhofer D, Ott I, Mehilli J, et al. Stem cell mobilization by granulocyte colonystimulating factor in patients with acute myocardial infarction: a randomized controlled trial. J Am Med Assoc 2006; 295: 1003-1010.